In mothers who later develop breast cancer, having breast-fed a child may reduce the risk of cancer recurrence.

Decitabine, a cancer therapeutic that inhibits DNA methylation, produces variable antitumor response rates in patients with solid tumors that might be leveraged clinically with identification of a predictive biomarker. In this study, we profiled the re...

Decitabine, a cancer therapeutic that inhibits DNA methylation, has elicited moderate to low response rates in patients with solid tumors. Despite efforts to identify responders based on DNA methylation, a marker for decitabine activity has yet to be d...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic malignancies. PDAC builds a tumor microenvironment that plays critical roles in tumor progression and metastasis. However, the relationship between chemotherapy and modulatio...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic malignancies. PDAC builds a tumor microenvironment that plays critical roles in tumor progression and metastasis. However, the relationship between chemotherapy and modulatio...